Exelixis
EXEL
#1572
Rank
NZ$23.99 B
Marketcap
NZ$95.47
Share price
0.23%
Change (1 day)
26.65%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company